Apyx Medical Corp. (APYX) Tops Q1 EPS by 3c ; Offers Guidance

Apyx Medical Corp. (NASDAQ: APYX) reported Q1 EPS of ($0.10), $0.03 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $12.1 million versus the consensus estimate of $10.81 million.

GUIDANCE:

Apyx Medical Corp. sees FY2023 revenue of $59-62 million, versus the consensus of $58.053 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance